U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
183721183721Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)CompletedNo Results AvailableSolid Tumor CancerDrug: lapatinib and docetaxelhttps://ClinicalTrials.gov/show/NCT00148902
183722183722Double-Blind, Multicenter Study to Assess the Efficacy of Bilateral Pallidal Stimulation in Patients With Medically Refractory Primary Cervical DystoniaCompletedNo Results AvailableCervical DystoniaDevice: Deep brain stimulation (DBS)https://ClinicalTrials.gov/show/NCT00148889
183723183723TBP Study With Capecitabine Plus Minus TrastuzumabCompletedNo Results AvailableBreast CancerDrug: Capecitabine|Drug: Trastuzumabhttps://ClinicalTrials.gov/show/NCT00148876
183724183724Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis CCompletedNo Results AvailableHepatitis C, ChronicDrug: Peg-interferon alpha 2a (drug)|Drug: Ribavirin (drug)|Drug: Interferon gamma (drug)https://ClinicalTrials.gov/show/NCT00148863
183725183725Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 PatientsTerminatedNo Results AvailableHIV-Associated Lipodystrophy Syndrome|HIV InfectionsDrug: Pioglitazonehttps://ClinicalTrials.gov/show/NCT00148850
183726183726Efficacy of Prazosin Versus Placebo Associated With Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe FibrosisActive, not recruitingNo Results AvailableHepatitis C, Chronic|FibrosisDrug: Peg-interferon alpha 2b (drug)|Drug: Ribavirin (drug)|Drug: Prazosin (drug)https://ClinicalTrials.gov/show/NCT00148837
183727183727Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults.CompletedNo Results AvailableHIV InfectionsBiological: 7-valent pneumococcal conjugate vaccine (vaccine)|Biological: 23-valent pneumococcal conjugate vaccine (vaccine)https://ClinicalTrials.gov/show/NCT00148824
183728183728Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)CompletedHas ResultsNon Small Cell Lung Cancer (NSCLC)Drug: cetuximab + cisplatin + vinorelbine|Drug: cisplatin + vinorelbinehttps://ClinicalTrials.gov/show/NCT00148798
183729183729A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and AmprenavirCompletedNo Results AvailableHIV InfectionsDrug: Indinavir/Ritonavir/Fosamprenavirhttps://ClinicalTrials.gov/show/NCT00148785
183730183730Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone TherapyCompletedNo Results AvailableProstate CancerDrug: Erlotinib (Tarceva)https://ClinicalTrials.gov/show/NCT00148772
183731183731Kaletra Sex/Gender Pharmacokinetics (PK) StudyCompletedHas ResultsHIV InfectionsDrug: LPV/rhttps://ClinicalTrials.gov/show/NCT00148759
183732183732Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic DermatitisCompletedNo Results AvailableModerate to Severe Atopic DermatitisDrug: Pimecrolimus|Drug: Tacrolimus|Drug: Prednisolone|Drug: Ciclosporin A|Drug: Dermatophttps://ClinicalTrials.gov/show/NCT00148746
183733183733CHIZAP: Community- and Health Facility-Based Intervention With Zinc as Adjuvant Therapy for Childhood PneumoniaCompletedHas ResultsPneumoniaDrug: Zinchttps://ClinicalTrials.gov/show/NCT00148733
183734183734Capecitabine in Women With Operable Breast CancerActive, not recruitingNo Results AvailableInvasive Breast Carcinoma|Primary Invasive Breast Cancer|Stage I Breast Cancer|Stage II Breast Cancer|Stage III Breast CancerDrug: Capecitabinehttps://ClinicalTrials.gov/show/NCT00148720
183735183735Study of Xyotax (CT-2103) in Patients With Metastatic Breast CancerCompletedNo Results AvailableBreast Cancer|Metastatic Breast CancerDrug: CT-2103 (Xyotax)https://ClinicalTrials.gov/show/NCT00148707
183736183736Preoperative Cisplatin in Early Stage Breast CancerCompletedNo Results AvailableBreast CancerDrug: Cisplatinhttps://ClinicalTrials.gov/show/NCT00148694
183737183737Preoperative Herceptin and Navelbine for Breast CancerActive, not recruitingNo Results AvailableBreast Cancer|Stage II Breast Cancer|Stage III Breast CancerDrug: Herceptin|Drug: Navelbine|Drug: Doxorubicin|Drug: Cyclophosphamide|Drug: Paclitaxelhttps://ClinicalTrials.gov/show/NCT00148681
183738183738Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast CancerCompletedHas ResultsBreast CancerDrug: Herceptin|Drug: Navelbine|Drug: Taxotere|Drug: Carboplatinhttps://ClinicalTrials.gov/show/NCT00148668
183739183739Educational Interventions for Patients With DCISCompletedNo Results AvailableDCISDevice: Decision Boardhttps://ClinicalTrials.gov/show/NCT00148655
183740183740Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)CompletedNo Results AvailableRespiratory FailureDevice: silver salts coated endotracheal tube|Device: uncoated endotracheal tubehttps://ClinicalTrials.gov/show/NCT00148642
183741183741Treatment and Prevention of Severe Anemia in Pregnant Zanzibari WomenActive, not recruitingNo Results AvailableAnemia|Low Birth Weight|Neonatal MortalityDrug: multivitamin, mebendazolehttps://ClinicalTrials.gov/show/NCT00148629
183742183742Memantine for the Treatment of Negative SymptomatologyTerminatedNo Results AvailableChronic SchizophreniaDrug: Memantinehttps://ClinicalTrials.gov/show/NCT00148616
183743183743Montelukast in the Treatment of Duodenal EosinophiliaCompletedNo Results AvailableEosinophilic Gastroenteritis|DyspepsiaDrug: montelukasthttps://ClinicalTrials.gov/show/NCT00148603
183744183744Memantine for the Prevention of Negative SymptomatologyTerminatedNo Results AvailableSchizophreniaDrug: Memantine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00148590
183745183745Pain Relief by Applying TENS on Acupuncture Points During the First Stage of LabourActive, not recruitingNo Results AvailablePain Relief at First StageDevice: Transcutaneous Electrical Nerve Stimulationhttps://ClinicalTrials.gov/show/NCT00148577
183746183746Energy Homeostasis Under Treatment With Atypical AntipsychoticsCompletedNo Results AvailableSchizophreniaDrug: olanzapine|Drug: Ziprasidonehttps://ClinicalTrials.gov/show/NCT00148564
183747183747Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.Active, not recruitingNo Results AvailableAge-Related Macular DegenerationDrug: Triamcinolone Acetonidehttps://ClinicalTrials.gov/show/NCT00148551
183748183748Type 1 Diabetes Aerobic and Resistance Exercise (T1-DARE)CompletedNo Results AvailableDiabetes Mellitus, Type 1Behavioral: Resistance and/or Aerobic Exercisehttps://ClinicalTrials.gov/show/NCT00148538
183749183749The Study of Automated Telephone Programs for the Maintenance of Dietary ChangeCompletedNo Results AvailableCancerBehavioral: Social Cognitive Theory|Behavioral: goal system theoryhttps://ClinicalTrials.gov/show/NCT00148525
183750183750A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor FCompletedNo Results AvailableParkinson DiseaseDrug: 1. Tesofensine (NS 2330)https://ClinicalTrials.gov/show/NCT00148512

* Görseller ve İçerik tekif hakkına sahip olabilir